Probiotics-derived metabolite ameliorates skin allergy by promoting differentiation of FOXP3+ regulatory T cells
- Authors
- Kang, H.-J.; Kim, G.-C.; Lee, C.-G.; Park, S.; Sharma, G.; Verma, R.; Im, S.-H.; Kwon, H.-K.
- Issue Date
- 2021-04
- Publisher
- Mosby Inc.
- Citation
- Journal of Allergy and Clinical Immunology, v.147, no.4, pp.1517 - 1521
- Abstract
- [No abstract available]
- Keywords
- probiotic agent; transcription factor FOXP3; Article; drug effect; drug efficacy; drug mechanism; human; immunomodulation; nonhuman; priority journal; regulatory T lymphocyte; skin allergy; contact hypersensitivity; Foxp3; Regulatory T cells; probiotics; metabolite; propionate; skin allergy; atopic dermatitis
- ISSN
- 0091-6749
- URI
- https://pubs.kist.re.kr/handle/201004/117233
- DOI
- 10.1016/j.jaci.2020.11.040
- Appears in Collections:
- KIST Article > 2021
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.